| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $223K | — |
| Cost of Revenue | $107K | — |
| Gross Profit | $115K | — |
| R&D Expense | $3.0M | -33.1% |
| SG&A Expense | $8.6M | +99.1% |
| Operating Income | -$31.5M | -174.1% |
| Pre-tax Income | -$5.3M | +84.3% |
| Income Tax | $795 | — |
| Net Income | -$5.4M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.5M | +115.8% |
| Accounts Receivable | $22K | -27.6% |
| Current Assets | $3.3M | +97.9% |
| Total Assets | $4.1M | +140.9% |
| Current Liabilities | $13.8M | +2044.8% |
| Total Liabilities | $14.0M | +549.3% |
| Stockholders' Equity | -$9.9M | -2063.8% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.6M | -52.6% |
| Investing Cash Flow | $77K | — |
| Financing Cash Flow | $21.7M | +93.8% |
| EPS (Basic) | -$1.15 | +99.9% |
| EPS (Diluted) | -$1.15 | +99.9% |